StockData
ProKidney Corp. logo

ProKidney Corp. (PROK) stock

PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.10+0.06 (+5.77%)

Close on Nov 17, 2026Market cap $332.56MP/E –Yield –

ProKidney price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

No price to book ratio figures for ProKidney

ProKidney has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More ProKidney figures

See a number that looks wrong?